V. A. Kondratiuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
V. A. Kondratiuk has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- I. A. Mazanovych
Shalimov National Research Center of Surgery and Transplantation, Kyiv
5 shared publications - Volodymyr Mykhailovych Kopchak
Shalimov National Scientific Center of Surgery and Transplantation of the National Academy of Medical Sciences of Ukraine, Kyiv
3 shared publications - Ihor Vasylovych Khomiak
Національний інститут хірургії та трансплантології імені О. О. Шалімова НАМН України, м. Київ
2 shared publications - Liudmyla Oleksandrivna Pererva
O. O. Shalimov National Institute of Surgery and Transplantology of NAMS of Ukraine, Kyiv
2 shared publications - Mykhailo Zagriichuk
Heart Institute of the Ministry of Health of Ukraine Candidate of Medical Sciences, Head of the Department of Transplantation and Surgery of Abdominal Organs
2 shared publications - P. A. Azadov
O. O. Shalimov National Institute of Surgery and Transplantology of NAMS of Ukraine, Kyiv
2 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (3) , 10-17
Experience in the Treatment of Pancreatic Hemorrhage as a Complication of Chronic Pancreatitis
Objective. To systematize the results of various treatment methods for patients with pancreatic hemorrhage as a complication of chronic pancreatitis. Materials and Methods. A retrospective analysis was conducted of the treatment outcomes of 47 patients with pancreatic hemorrhage against a background of chronic pancreatitis during the period from 2015 to 2025. There were 36 men and 11 women aged 25 to 71 years. The mean age of the patients was (47 ± 11) years. The diagnosis was verified based on the clinical triad (pain, bleeding, hyperamylasemia) and data from multislice computed tomography of the abdominal organs and digital subtraction angiography, which confirmed the presence of pseudocysts or pseudoaneurysms. The treatment strategy consisted of performing endovascular interventions (in 33 patients), open surgeries (in 9 patients), and conservative therapy (in 5 patients). Treatment efficacy was assessed based on the frequency of hemostasis achievement, recurrence, and mortality rates. Results. Clinically, pain was the predominant symptom in all patients (100%), while overt signs of gastrointestinal bleeding varied (melena–12.8%, hematemesis–4.3%, and a combination of symptoms–4.2%). Anemia was detected in 34.0% of patients, and hyperamylasemia in 23.4%. According to imaging data, the main sources of bleeding were the gastric and duodenal (42.9%) and splenic (30.0%) arteries; calcifications were detected in the immediate vicinity of the affected vessel in 42.6% of patients. Endovascular hemostasis, performed in 33 (70.2%) patients, had a technical success rate of 100%. The primary clinical efficacy of the method was 61.7%, and the overall efficacy after repeat angiographic interventions was 70.2%. Surgical treatment, performed in 9 (19.2%) patients with recurrences or hemodynamic instability, had a 100% success rate. The overall efficacy of the multimodal approach was 97.9%, mortality was 2.1%, and the recurrence rate was 19.2%. Predictors of an unfavorable course were identified as massive blood loss, infection of a pseudocyst, localization in the gastro-duodenal artery basin, and the presence of pararterial calcifications. Conclusions. The implementation of a multimodal approach with the priority use of endovascular hemostasis as a first-line method is a highly effective and safe strategy for treating pancreatic hemorrhage, allowing for successful clinical outcomes with a minimal mortality rate.
- 19 June 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (3) , 10-17
Open AccessExperience in the Treatment of Pancreatic Hemorrhage as a Complication of Chronic Pancreatitis
Objective. To systematize the results of various treatment methods for patients with pancreatic hemorrhage as a complication of chronic pancreatitis. Materials and Methods. A retrospective analysis was conducted of the treatment outcomes of 47 patients with pancreatic hemorrhage against a background of chronic pancreatitis during the period from 2015 to 2025. There were 36 men and 11 women aged 25 to 71 years. The mean age of the patients was (47 ± 11) years. The diagnosis was verified based on the clinical triad (pain, bleeding, hyperamylasemia) and data from multislice computed tomography of the abdominal organs and digital subtraction angiography, which confirmed the presence of pseudocysts or pseudoaneurysms. The treatment strategy consisted of performing endovascular interventions (in 33 patients), open surgeries (in 9 patients), and conservative therapy (in 5 patients). Treatment efficacy was assessed based on the frequency of hemostasis achievement, recurrence, and mortality rates. Results. Clinically, pain was the predominant symptom in all patients (100%), while overt signs of gastrointestinal bleeding varied (melena–12.8%, hematemesis–4.3%, and a combination of symptoms–4.2%). Anemia was detected in 34.0% of patients, and hyperamylasemia in 23.4%. According to imaging data, the main sources of bleeding were the gastric and duodenal (42.9%) and splenic (30.0%) arteries; calcifications were detected in the immediate vicinity of the affected vessel in 42.6% of patients. Endovascular hemostasis, performed in 33 (70.2%) patients, had a technical success rate of 100%. The primary clinical efficacy of the method was 61.7%, and the overall efficacy after repeat angiographic interventions was 70.2%. Surgical treatment, performed in 9 (19.2%) patients with recurrences or hemodynamic instability, had a 100% success rate. The overall efficacy of the multimodal approach was 97.9%, mortality was 2.1%, and the recurrence rate was 19.2%. Predictors of an unfavorable course were identified as massive blood loss, infection of a pseudocyst, localization in the gastro-duodenal artery basin, and the presence of pararterial calcifications. Conclusions. The implementation of a multimodal approach with the priority use of endovascular hemostasis as a first-line method is a highly effective and safe strategy for treating pancreatic hemorrhage, allowing for successful clinical outcomes with a minimal mortality rate.
- Open Access
- 19 June 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (3) , 52-57
Organ-preserving treatment of splenomegaly in portal hypertension: clinical outcomes 12 months after partial embolization of the splenic artery
Objective. To evaluate the hematological effects and clinical efficacy of partial splenic artery embolization in the treatment of splenomegaly and hypersplenism in patients with portal hypertension caused by chronic liver diseases. Materials and Methods. A retrospective cohort study included 49 patients with chronic liver diseases of various etiologies. Spleen volume was determined using standardized ultrasound at the start of treatment and after 12 months; platelet counts were recorded, and the severity class was determined according to the Child–Pugh classification, along with the score on the Model for End-Stage Liver Disease (MELD) scale. All patients underwent combined distal and proximal splenic artery embolization. Results were evaluated based on absolute and relative changes in spleen volume, platelet count dynamics, and their correlation. Results. The mean spleen volume prior to partial splenic artery embolization was 975 cm³, and 12 months after the procedure, it was 605 cm³ (mean reduction: 36%). In contrast, the mean platelet count increased from 63.9 × 10⁹/L before surgery to 126.4 × 10⁹/L (+118%) 12 months later. The most pronounced hematological response was observed in patients with massive splenomegaly (organ volume exceeding 1000 cm³). A statistically significant moderate correlation was established between splenic volume reduction and the increase in platelet count (r = –0.53; p < 0.001). The use of 2D perfusion mapping confirmed the presence of marked splenic hyperperfusion in all patients prior to partial embolization of the splenic artery +3. Conclusions. Following partial embolization of the splenic artery, there is a consistent and clinically significant reduction in spleen volume with sustained correction of thrombocytopenia. The effect is most pronounced in cases of severe splenomegaly. Partial splenic artery embolization may serve as an effective organ-preserving alternative to splenectomy in the treatment of hypersplenism in portal hypertension.
- 19 June 2026
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 93 (3) , 52-57
Open AccessOrgan-preserving treatment of splenomegaly in portal hypertension: clinical outcomes 12 months after partial embolization of the splenic artery
Objective. To evaluate the hematological effects and clinical efficacy of partial splenic artery embolization in the treatment of splenomegaly and hypersplenism in patients with portal hypertension caused by chronic liver diseases. Materials and Methods. A retrospective cohort study included 49 patients with chronic liver diseases of various etiologies. Spleen volume was determined using standardized ultrasound at the start of treatment and after 12 months; platelet counts were recorded, and the severity class was determined according to the Child–Pugh classification, along with the score on the Model for End-Stage Liver Disease (MELD) scale. All patients underwent combined distal and proximal splenic artery embolization. Results were evaluated based on absolute and relative changes in spleen volume, platelet count dynamics, and their correlation. Results. The mean spleen volume prior to partial splenic artery embolization was 975 cm³, and 12 months after the procedure, it was 605 cm³ (mean reduction: 36%). In contrast, the mean platelet count increased from 63.9 × 10⁹/L before surgery to 126.4 × 10⁹/L (+118%) 12 months later. The most pronounced hematological response was observed in patients with massive splenomegaly (organ volume exceeding 1000 cm³). A statistically significant moderate correlation was established between splenic volume reduction and the increase in platelet count (r = –0.53; p < 0.001). The use of 2D perfusion mapping confirmed the presence of marked splenic hyperperfusion in all patients prior to partial embolization of the splenic artery +3. Conclusions. Following partial embolization of the splenic artery, there is a consistent and clinically significant reduction in spleen volume with sustained correction of thrombocytopenia. The effect is most pronounced in cases of severe splenomegaly. Partial splenic artery embolization may serve as an effective organ-preserving alternative to splenectomy in the treatment of hypersplenism in portal hypertension.
- Open Access
- 13 November 2024
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 91 (5) , 45-49
Endovascular treatment of postoperative gastrointestinal bleeding
Objective. To analyze the results of endovascular treatment of postoperative gastrointestinal bleeding. Materials and methods. During the period 2014–2024, 328 endovascular interventions were performed in 297 patients with postoperative gastrointestinal bleeding. The most common was vesicovaginal bleeding after pancreatic surgery. A total of 304 embolizations were performed and 24 stent grafts were installed. Results. In 253 (85.2%) patients, it was possible to diagnose the source of bleeding angiographically, and the bleeding was stopped with the help of embolization devices and stent grafts. In 44 (14.8%) patients, it was not possible to accurately diagnose the source of bleeding, and they underwent prophylactic embolization of the most likely source of bleeding. In 12 patients, embolization was repeated: in 6 patients it was performed twice, in 5 patients – three times, and in 1 patient – four times. In 16 (5.4%) patients, including 15 after prophylactic embolization, endovascular hemostasis was ineffective and they required surgical intervention. Conclusions. Endovascular treatment due to its minimal invasiveness, the possibility of repeated use, and the combination of diagnostic and therapeutic stages is the primary method in the treatment of postoperative gastrointestinal bleeding.
- 13 November 2024
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 91 (5) , 45-49
Open AccessEndovascular treatment of postoperative gastrointestinal bleeding
Objective. To analyze the results of endovascular treatment of postoperative gastrointestinal bleeding. Materials and methods. During the period 2014–2024, 328 endovascular interventions were performed in 297 patients with postoperative gastrointestinal bleeding. The most common was vesicovaginal bleeding after pancreatic surgery. A total of 304 embolizations were performed and 24 stent grafts were installed. Results. In 253 (85.2%) patients, it was possible to diagnose the source of bleeding angiographically, and the bleeding was stopped with the help of embolization devices and stent grafts. In 44 (14.8%) patients, it was not possible to accurately diagnose the source of bleeding, and they underwent prophylactic embolization of the most likely source of bleeding. In 12 patients, embolization was repeated: in 6 patients it was performed twice, in 5 patients – three times, and in 1 patient – four times. In 16 (5.4%) patients, including 15 after prophylactic embolization, endovascular hemostasis was ineffective and they required surgical intervention. Conclusions. Endovascular treatment due to its minimal invasiveness, the possibility of repeated use, and the combination of diagnostic and therapeutic stages is the primary method in the treatment of postoperative gastrointestinal bleeding.
- Open Access
- 13 October 2024
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 91 (4) , 60-65
Possibilities of endovascular treatment of vascular complications in mine–blast trauma
Objective. To optimize approaches to endovascular treatment of posttraumatic false aneurysms and arteriovenous fistulas in patients with complications of mine–blast trauma. Materials and Methods. The results of examination and treatment of 9 patients with complications of mine–blast trauma were analyzed. False aneurysms of various localizations were detected in 5 (55.6%) patients, and arteriovenous fistulas of the same localization were detected in 4 (44.4%) patients. Results. We performed 5 endoprosthetics with the use of stent grafts to exclude lesions from the circulation, as well as 5 selective embolizations with coils. In 1 patient, embolization with endoprosthetics was performed simultaneously. In all 9 patients, the treatment was technically successful, that is, the technical success of the interventions was 100%. None of the patients had any complications. All patients regressed clinical symptoms after the intervention. Conclusions. Endovascular treatment of post–traumatic false aneurysms and arteriovenous fistulas in patients with mine–blast trauma is highly effective. In all 9 patients with arteriovenous fistulas and false aneurysms, endoprosthetics with stent grafts and selective embolization of lesions with complex anatomy were successfully performed. Further study of the long–term results of treatment of these patients is necessary to increase technical and clinical success.
- 13 October 2024
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 91 (4) , 60-65
Open AccessPossibilities of endovascular treatment of vascular complications in mine–blast trauma
Objective. To optimize approaches to endovascular treatment of posttraumatic false aneurysms and arteriovenous fistulas in patients with complications of mine–blast trauma. Materials and Methods. The results of examination and treatment of 9 patients with complications of mine–blast trauma were analyzed. False aneurysms of various localizations were detected in 5 (55.6%) patients, and arteriovenous fistulas of the same localization were detected in 4 (44.4%) patients. Results. We performed 5 endoprosthetics with the use of stent grafts to exclude lesions from the circulation, as well as 5 selective embolizations with coils. In 1 patient, embolization with endoprosthetics was performed simultaneously. In all 9 patients, the treatment was technically successful, that is, the technical success of the interventions was 100%. None of the patients had any complications. All patients regressed clinical symptoms after the intervention. Conclusions. Endovascular treatment of post–traumatic false aneurysms and arteriovenous fistulas in patients with mine–blast trauma is highly effective. In all 9 patients with arteriovenous fistulas and false aneurysms, endoprosthetics with stent grafts and selective embolization of lesions with complex anatomy were successfully performed. Further study of the long–term results of treatment of these patients is necessary to increase technical and clinical success.
- Open Access
- 30 March 2024
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 1,p. 8-16
Modern endovascular treatment strategies in the management of postpancreatectomy haemorrhage in patients with pancreatic cancer
Objective — to determine the occurrence and management of postpancreatectomy haemorrhage in pancreatic cancer patients, as well as to identify effective treatment strategies to improve patient outcomes. Materials and methods. From January 2010 to December 2022, 878 patients who underwent radical pancreatic resections for malignant tumours were retrospectively analysed. Patients were divided into two groups. The main group consisted of 500 patients who were treated in the clinic from 2016 to 2022. In the main group, postpancreatectomy haemorrhage occurred in 31 (6.2%) patients. These patients were treated according to our diagnostic and treatment algorithm, using endovascular techniques as the first step of treatment. The comparison group consisted of 378 patients who were treated in our department from 2010 to 2015. In the comparison group, postpancreatectomy haemorrhage occurred in 20 (5.3%) patients. These patients were treated according to standard approaches. The definition of postpancreatectomy haemorrhage proposed by the International Study Group of Pancreatic Surgery was used in our research. Results. Out of 31 patients in the main group, 16 (51.6%) had endovascular embolisation. A total of 10 patients underwent endovascular occlusion, whereas 5 patients experienced cessation of bleeding with the use of a stent graft. Angiography did not detect the cause of bleeding in 3 (9.7%) individuals in the main group. They underwent laparotomy with subsequent haemostasis. 11 (35.5%) patients underwent open surgical interventions. In the main group, one (3.2%) patient died due to the emergence of infectious complications after laparotomy and subsequent haemostasis. 2 (10%) patients underwent endovascular haemostasis, while 15 (75%) patients underwent relaparotomy with haemostasis. In the comparison group, 6 (30%) patients died after open relaparotomies. Conclusions. The initial course of action for managing postpancreatectomy haemorrhage involves the implementation of endovascular techniques, wherein stent grafts are used to address bleeding originating from the main blood vessel. The application of advanced treatment strategies that optimised the use of minimally invasive endovascular techniques resulted in a notable decrease in the mortality rate associated with postpancreatectomy bleeding from 30% to 3.2% (χ2=7.3, p=0.006). Ensuring 24/7 access to endovascular treatment, which can be provided exclusively in high‑volume centres, is imperative for improving the treatment outcomes of patients with pancreatic and periampullary cancer.
- 30 March 2024
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 1,p. 8-16
Open AccessModern endovascular treatment strategies in the management of postpancreatectomy haemorrhage in patients with pancreatic cancer
Objective — to determine the occurrence and management of postpancreatectomy haemorrhage in pancreatic cancer patients, as well as to identify effective treatment strategies to improve patient outcomes. Materials and methods. From January 2010 to December 2022, 878 patients who underwent radical pancreatic resections for malignant tumours were retrospectively analysed. Patients were divided into two groups. The main group consisted of 500 patients who were treated in the clinic from 2016 to 2022. In the main group, postpancreatectomy haemorrhage occurred in 31 (6.2%) patients. These patients were treated according to our diagnostic and treatment algorithm, using endovascular techniques as the first step of treatment. The comparison group consisted of 378 patients who were treated in our department from 2010 to 2015. In the comparison group, postpancreatectomy haemorrhage occurred in 20 (5.3%) patients. These patients were treated according to standard approaches. The definition of postpancreatectomy haemorrhage proposed by the International Study Group of Pancreatic Surgery was used in our research. Results. Out of 31 patients in the main group, 16 (51.6%) had endovascular embolisation. A total of 10 patients underwent endovascular occlusion, whereas 5 patients experienced cessation of bleeding with the use of a stent graft. Angiography did not detect the cause of bleeding in 3 (9.7%) individuals in the main group. They underwent laparotomy with subsequent haemostasis. 11 (35.5%) patients underwent open surgical interventions. In the main group, one (3.2%) patient died due to the emergence of infectious complications after laparotomy and subsequent haemostasis. 2 (10%) patients underwent endovascular haemostasis, while 15 (75%) patients underwent relaparotomy with haemostasis. In the comparison group, 6 (30%) patients died after open relaparotomies. Conclusions. The initial course of action for managing postpancreatectomy haemorrhage involves the implementation of endovascular techniques, wherein stent grafts are used to address bleeding originating from the main blood vessel. The application of advanced treatment strategies that optimised the use of minimally invasive endovascular techniques resulted in a notable decrease in the mortality rate associated with postpancreatectomy bleeding from 30% to 3.2% (χ2=7.3, p=0.006). Ensuring 24/7 access to endovascular treatment, which can be provided exclusively in high‑volume centres, is imperative for improving the treatment outcomes of patients with pancreatic and periampullary cancer.
- Open Access
- 22 March 2024
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 90 (5) , 9-15
Modern principles of diagnosis and treatment of post–pancreatic resection bleeding
Objective. To improve the results of treatment of patients with post–pancreatic resection bleeding. Materials and methods. The results of treatment of 827 patients who underwent radical resection of the pancreas for malignant tumours in the period from 2010 to 2021 were analysed. The patients were divided into two groups: the main group – 449 patients who were treated at the clinic from 2016 to 2021, and the control group – 378 patients who were treated in the clinic from 2010 to 2015. Postpancreatectomy bleeding occurred in 27 (6.0%) patients in the main group who were treated according to the developed diagnostic and therapeutic algorithm with the maximum use of endovascular techniques, and in 20 (5.3%) patients in the control group who received standard treatment. Results. X–ray endovascular bleeding control was performed in 14 (51.9%) of 27 patients in the main group: X–ray endovascular occlusion – in 9, by means of stent graft placement – in 5. In 3 (11.1%) patients of the main group, the source of bleeding was not detected during angiography, and they underwent laparotomy with subsequent bleeding control. Complications after X–ray endovascular occlusion occurred in 1 (11.1%) patient, and there were no complications after stent graft placement. Open surgical interventions were performed in 13 (48.1%) patients. One (3.7%) patient died after laparotomy with bleeding control due to the development of further purulent–septic complications. In the control group, X–ray endovascular bleeding control was performed in 3 (15%) patients, and relaparotomy with bleeding control in 17 (85%) patients. 6 (30%) patients died after open reoperative interventions. Conclusions. Endovascular techniques for stopping post–pancreatic transplantation bleeding are highly effective and safe with favourable technical and clinical results. They are advisable as the first step in the treatment of postpancreatic surgery bleeding with stent grafts in case of bleeding from the great vessels.
- 22 March 2024
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 90 (5) , 9-15
Open AccessModern principles of diagnosis and treatment of post–pancreatic resection bleeding
Objective. To improve the results of treatment of patients with post–pancreatic resection bleeding. Materials and methods. The results of treatment of 827 patients who underwent radical resection of the pancreas for malignant tumours in the period from 2010 to 2021 were analysed. The patients were divided into two groups: the main group – 449 patients who were treated at the clinic from 2016 to 2021, and the control group – 378 patients who were treated in the clinic from 2010 to 2015. Postpancreatectomy bleeding occurred in 27 (6.0%) patients in the main group who were treated according to the developed diagnostic and therapeutic algorithm with the maximum use of endovascular techniques, and in 20 (5.3%) patients in the control group who received standard treatment. Results. X–ray endovascular bleeding control was performed in 14 (51.9%) of 27 patients in the main group: X–ray endovascular occlusion – in 9, by means of stent graft placement – in 5. In 3 (11.1%) patients of the main group, the source of bleeding was not detected during angiography, and they underwent laparotomy with subsequent bleeding control. Complications after X–ray endovascular occlusion occurred in 1 (11.1%) patient, and there were no complications after stent graft placement. Open surgical interventions were performed in 13 (48.1%) patients. One (3.7%) patient died after laparotomy with bleeding control due to the development of further purulent–septic complications. In the control group, X–ray endovascular bleeding control was performed in 3 (15%) patients, and relaparotomy with bleeding control in 17 (85%) patients. 6 (30%) patients died after open reoperative interventions. Conclusions. Endovascular techniques for stopping post–pancreatic transplantation bleeding are highly effective and safe with favourable technical and clinical results. They are advisable as the first step in the treatment of postpancreatic surgery bleeding with stent grafts in case of bleeding from the great vessels.
- Open Access
- 1 March 2024
- Published by Professional Event, LLC in Reproductive health of woman
- No. 1,p. 53-61
Clinical experience of using the technique of uterine artery embolization in the treatment of submucous uterine fibroids in the Vidar Medical Center, Vinnytsia (2008–2022)
Myoma of the uterus is a benign neoplasm. The technique of uterine artery embolization (UAE) is used to treat uterine fibroids and is highly effective. The principle of embolization is based on the fact that all blood vessels that supply the uterus end in the endometrium.During UAE small parts are injected – emboli, which are spread along these vessels with the blood flow. In the vessels of the myoma the emboli cannot pass through the capsule of the myoma, so they block the vessels that supply it with blood. This leads to the cessation of blood supply to myomatous nodes, and subsequently there is a decrease in the size of these nodes, on average by 50–60% during the year, with a gradual decrease during the following years of life.This minimally invasive procedure is performed under local anesthesia – after femoral artery puncture, with X-ray control of angiography and intraoperative assessment of blood flow in fibroid nodes using ultrasound (US).Over 15 years of work, 1,400 UAE operations of uterine fibroids have been performed, of which more than 70 cases are UAE of submucosal myomas. Later, when the clinical picture of expulsion of these submucosal nodes appeared, transvaginal myomectomy was performed. Such a combined technique demonstrated high efficiency.The article describes clinical cases of patients who received treatment of large submucosal myoma by the UAE method followed by transvaginal myomectomy of the nascent node. In total, 5 clinical cases are described, the results of ultrasound, macropreparations, and colposcopic images are presented. A clinical case of a uterine myoma, the size of which corresponded to 21 weeks of pregnancy and a volume of 1500 cm3, is presented: after the above complex treatment method the volume of the uterus decreased according to ultrasound examination to 122 cm3. Also, a clinical case of a patient with uterine myoma, massive bleeding, whose hemoglobin level was 67 g/l is described. The patient was performed by UAE followed by transvaginal myomectomy for expulsion of the submucosal node.So, the described complex method of treatment of submucous uterine fibroids demonstrated high efficiency of clinical results.
- 1 March 2024
- Published by Professional Event, LLC in Reproductive health of woman
- No. 1,p. 53-61
Open AccessClinical experience of using the technique of uterine artery embolization in the treatment of submucous uterine fibroids in the Vidar Medical Center, Vinnytsia (2008–2022)
Myoma of the uterus is a benign neoplasm. The technique of uterine artery embolization (UAE) is used to treat uterine fibroids and is highly effective. The principle of embolization is based on the fact that all blood vessels that supply the uterus end in the endometrium.During UAE small parts are injected – emboli, which are spread along these vessels with the blood flow. In the vessels of the myoma the emboli cannot pass through the capsule of the myoma, so they block the vessels that supply it with blood. This leads to the cessation of blood supply to myomatous nodes, and subsequently there is a decrease in the size of these nodes, on average by 50–60% during the year, with a gradual decrease during the following years of life.This minimally invasive procedure is performed under local anesthesia – after femoral artery puncture, with X-ray control of angiography and intraoperative assessment of blood flow in fibroid nodes using ultrasound (US).Over 15 years of work, 1,400 UAE operations of uterine fibroids have been performed, of which more than 70 cases are UAE of submucosal myomas. Later, when the clinical picture of expulsion of these submucosal nodes appeared, transvaginal myomectomy was performed. Such a combined technique demonstrated high efficiency.The article describes clinical cases of patients who received treatment of large submucosal myoma by the UAE method followed by transvaginal myomectomy of the nascent node. In total, 5 clinical cases are described, the results of ultrasound, macropreparations, and colposcopic images are presented. A clinical case of a uterine myoma, the size of which corresponded to 21 weeks of pregnancy and a volume of 1500 cm3, is presented: after the above complex treatment method the volume of the uterus decreased according to ultrasound examination to 122 cm3. Also, a clinical case of a patient with uterine myoma, massive bleeding, whose hemoglobin level was 67 g/l is described. The patient was performed by UAE followed by transvaginal myomectomy for expulsion of the submucosal node.So, the described complex method of treatment of submucous uterine fibroids demonstrated high efficiency of clinical results.
- Open Access
- 20 February 2023
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 90 (1) , 75-78
Severe hemobilia after pancreaticoduodenal resection, caused by false aneurysm of right branch of a. hepatica propria as a complication of transcutaneous transhepatic cholangiostomy
Severe hemobilia after pancreaticoduodenal resection, caused by false aneurysm of right branch of a. hepatica propria as a complication of transcutaneous transhepatic cholangiostomy
- 20 February 2023
- Published by Liga-Inform, Ltd. in The Ukrainian Journal of Clinical Surgery
- Vol. 90 (1) , 75-78
Open AccessSevere hemobilia after pancreaticoduodenal resection, caused by false aneurysm of right branch of a. hepatica propria as a complication of transcutaneous transhepatic cholangiostomy
Severe hemobilia after pancreaticoduodenal resection, caused by false aneurysm of right branch of a. hepatica propria as a complication of transcutaneous transhepatic cholangiostomy
- Open Access
- 3 February 2022
- Published by NGO Allukrainian Association of Endovascular Neuroradiology in Ukrainian Interventional Neuroradiology and Surgery
- Vol. 37 (3) , 57-61
Endovascular treatment of common hepatocellular carcinoma: the experience of one center
Objective ‒ to determine the place of transarterial chemoembolization of the liver (TACE) in the modern protocol for treating patients with common hepatocellular carcinoma and by optimizing indications and contraindications to improve the results of complex treatment of these patients.Materials and methods. During the period 2011‒2021 242 TACE procedures were performed on 112 patients with inoperable hepatocellular carcinoma. Conventional lipidol embolization (c-TACE) was performed in 53 patients, procedures with drug eluting beads (DEB-TACE) ‒ in 58. All patients underwent a minimum of 1, a maximum of 5 TACE procedures. The decision to re-TACE was made individually, according the prevalence of the lesion (for bilobar lesions performed at least 2 unilobar TACE) and the tumor’s response to the intervention. Results. TACE results were evaluated according to mRECIST criteria: complete tumor response (CR) was noted in 3 (2.7 %) cases, partial (PR) ‒ in 68 (60.7 %) cases, process stabilization (SD) ‒ in 29 (25.9 %), progression (PD) ‒ 12 (10.7 %) cases. According by the obtained results, convincing data for the superiority of any of the applied TACE methods were not found. Repeated TACE courses increase the overall effectiveness of the treatment. Conclusions. The use of TACE in patients with inoperable hepatocellular carcinoma allows with minimal invasiveness to reduce or stabilize tumor growth in 89.3 % of cases. Repeated performance of the procedure allows to increase the treatment efficiency by 21.2 %.
- 3 February 2022
- Published by NGO Allukrainian Association of Endovascular Neuroradiology in Ukrainian Interventional Neuroradiology and Surgery
- Vol. 37 (3) , 57-61
Open AccessEndovascular treatment of common hepatocellular carcinoma: the experience of one center
Objective ‒ to determine the place of transarterial chemoembolization of the liver (TACE) in the modern protocol for treating patients with common hepatocellular carcinoma and by optimizing indications and contraindications to improve the results of complex treatment of these patients.Materials and methods. During the period 2011‒2021 242 TACE procedures were performed on 112 patients with inoperable hepatocellular carcinoma. Conventional lipidol embolization (c-TACE) was performed in 53 patients, procedures with drug eluting beads (DEB-TACE) ‒ in 58. All patients underwent a minimum of 1, a maximum of 5 TACE procedures. The decision to re-TACE was made individually, according the prevalence of the lesion (for bilobar lesions performed at least 2 unilobar TACE) and the tumor’s response to the intervention. Results. TACE results were evaluated according to mRECIST criteria: complete tumor response (CR) was noted in 3 (2.7 %) cases, partial (PR) ‒ in 68 (60.7 %) cases, process stabilization (SD) ‒ in 29 (25.9 %), progression (PD) ‒ 12 (10.7 %) cases. According by the obtained results, convincing data for the superiority of any of the applied TACE methods were not found. Repeated TACE courses increase the overall effectiveness of the treatment. Conclusions. The use of TACE in patients with inoperable hepatocellular carcinoma allows with minimal invasiveness to reduce or stabilize tumor growth in 89.3 % of cases. Repeated performance of the procedure allows to increase the treatment efficiency by 21.2 %.
- Open Access
- 28 April 2019
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 86 (4) , 16-20
Рентгенендоваскулярна оклюзія судин наднирника як метод профілактики ускладнень при лапароскопічній адреналектомії з приводу феохромоцитоми
Мета. Оцінити результати застосування рентгенендоваскулярної селективної електрокоагуляційної оклюзії судин наднирника в лікуванні феохромоцитоми. Матеріали і методи. Проведено проспективне та ретроспективне дослідження результатів лікування 66 пацієнтів, яким виконали лапароскопічну адреналектомію (ЛА) з приводу феохромоцитоми за період з 2008 по 2018 р. Для порівняльного аналізу пацієнтів розподілили на дві групи: 1-ша група - 36 пацієнтів, яким за 24 год до ЛА виконували рентгенедоваскулярну селективну електрокоагуляційну оклюзію (РЕВСЕО) судин наднирника, 2-га група - 30 пацієнтів, яким виконали тільки ЛА. Проаналізовано середню тривалість оперативного втручання, об’єм крововтрати, гемодинамічні параметри, рівень метанефрину в сечі та ускладнення. Результати. За віком, статтю, локалізацією та розміром пухлини суттєвої різниці між обома групами хворих не було. Об’єм інтраопераційної крововтрати у пацієнтів 1-ї групи становив (50 ± 5,78) мл, 2-ї групи - (105,48 ± 84,41) мл (p < 0,00001). Під час госпіталізації середній рівень метанефрину в сечі у хворих 1-ї та 2-ї груп практично не відрізнялися - (1163,54 ± 931,5) мкг/24 год (153,0 - 4011,0 мкг/24 год) та (1097,69 ± 903,28) мкг/24 год (146,5 - 3350 мкг/24 год) відповідно (р=0,254), проте через 24 год після РЕВСЕО судин наднирників середній рівень метанефрину в сечі у пацієнтів 1-ї групи суттєво зменшився та становив (315,64 ± 111,51) мкг/24 год (108 - 614,51 мкг/24 год, р=0,00001). Тривалість оперативного втручання у хворих 1-ї та 2-ї груп була майже однаковою - відповідно (110,8 ± 44,88) та (113,3 ± 55,42) хв (p = 0,515). Гемодинамічну нестабільність спостерігали лише у 5 (16,7%) пацієнтів 2-ї групи. Ускладнення виникли у 4 (13,3%) пацієнтів 2-ї групи та у 1 (2,8%) пацієнті 1-ї групи. В обох групах жоден пацієнт не помер. Висновки. У порівнянні з ЛА мультидисциплінарний підхід є більш безпечним, швидким та ефективним у лікуванні пацієнтів з феохромоцитомою.
- 28 April 2019
- Published by Liga-Inform, Ltd. in Klinicheskaia khirurgiia
- Vol. 86 (4) , 16-20
Open AccessРентгенендоваскулярна оклюзія судин наднирника як метод профілактики ускладнень при лапароскопічній адреналектомії з приводу феохромоцитоми
Мета. Оцінити результати застосування рентгенендоваскулярної селективної електрокоагуляційної оклюзії судин наднирника в лікуванні феохромоцитоми. Матеріали і методи. Проведено проспективне та ретроспективне дослідження результатів лікування 66 пацієнтів, яким виконали лапароскопічну адреналектомію (ЛА) з приводу феохромоцитоми за період з 2008 по 2018 р. Для порівняльного аналізу пацієнтів розподілили на дві групи: 1-ша група - 36 пацієнтів, яким за 24 год до ЛА виконували рентгенедоваскулярну селективну електрокоагуляційну оклюзію (РЕВСЕО) судин наднирника, 2-га група - 30 пацієнтів, яким виконали тільки ЛА. Проаналізовано середню тривалість оперативного втручання, об’єм крововтрати, гемодинамічні параметри, рівень метанефрину в сечі та ускладнення. Результати. За віком, статтю, локалізацією та розміром пухлини суттєвої різниці між обома групами хворих не було. Об’єм інтраопераційної крововтрати у пацієнтів 1-ї групи становив (50 ± 5,78) мл, 2-ї групи - (105,48 ± 84,41) мл (p < 0,00001). Під час госпіталізації середній рівень метанефрину в сечі у хворих 1-ї та 2-ї груп практично не відрізнялися - (1163,54 ± 931,5) мкг/24 год (153,0 - 4011,0 мкг/24 год) та (1097,69 ± 903,28) мкг/24 год (146,5 - 3350 мкг/24 год) відповідно (р=0,254), проте через 24 год після РЕВСЕО судин наднирників середній рівень метанефрину в сечі у пацієнтів 1-ї групи суттєво зменшився та становив (315,64 ± 111,51) мкг/24 год (108 - 614,51 мкг/24 год, р=0,00001). Тривалість оперативного втручання у хворих 1-ї та 2-ї груп була майже однаковою - відповідно (110,8 ± 44,88) та (113,3 ± 55,42) хв (p = 0,515). Гемодинамічну нестабільність спостерігали лише у 5 (16,7%) пацієнтів 2-ї групи. Ускладнення виникли у 4 (13,3%) пацієнтів 2-ї групи та у 1 (2,8%) пацієнті 1-ї групи. В обох групах жоден пацієнт не помер. Висновки. У порівнянні з ЛА мультидисциплінарний підхід є більш безпечним, швидким та ефективним у лікуванні пацієнтів з феохромоцитомою.